A phase I/II study of RX-3117, an oral antimetabolite nucleoside, in combination with nab-paclitaxel (nab-pac) as first-line treatment of metastatic pancreatic cancer (met-PC): Preliminary results.

fluorocyclopentenylcytosine (RX-3117) - Rexahn

Abraxane (albumin-bound paclitaxel) - Celgene, Otsuka

paclitaxel - generics

https://meetinglibrary.asco.org/record/168765

Hani M. Babiker; Peter J. Schlegel; Lee G. Hicks; Andrea J. Bullock; Nafisa Burhani; Ely Benaim; Christine Peterson; Callie Heaton; Allyson J. Ocean

Jan 15, 2019